The
impact of O2 on olefin metathesis promoted by Ru-NHC and
Ru-CAAC catalysts is examined (NHC = N-heterocyclic carbene; CAAC
= cyclic alkyl amino carbene). An atmosphere of 8% O2 in
Ar is found to decrease turnover numbers by ca. 15–95% in ring-closing
metathesis, including macrocyclization reactions. All H2IMes catalysts studied, irrespective of their ease of initiation,
exhibit broadly similar O2-sensitivity, within the middle
of this range. Much greater disparities in performance emerge for
the CAAC catalysts, which exhibit an unexpected correlation between
reactivity and robustness. Fast-initiating CAAC catalysts show greatest
resistance to O2 of all systems studied. Mechanistic studies
with the second-generation Grubbs catalyst RuCl2(H2IMes)(PCy3)(=CHPh), which contains the useful PCy3 and benzylidene reporter groups, suggest that [2 + 2] cycloaddition
of O2 dominates over the reported attack of O2 at the benzylidene ligand. At catalyst concentrations compatible
with NMR analysis (20 mM Ru), bimolecular coupling of Ru-4 is also a significant contributor to decomposition.
Many commercial drugs, as well as
upcoming pharmaceutically active
compounds in the pipeline, display aliphatic carboxylic acids or derivatives
thereof as key structural entities. Synthetic methods for rapidly
accessing isotopologues of such compounds are highly relevant for
undertaking critical pharmacological studies. In this paper, we disclose
a direct synthetic route allowing for full carbon isotope replacement
via a nickel-mediated alkoxycarbonylation. Employing a nickelII pincer complex ([(N2N)Ni–Cl]) in combination
with carbon-13 labeled CO, alkyl iodide, sodium methoxide, photocatalyst,
and blue LED light, it was possible to generate the corresponding
isotopically labeled aliphatic carboxylates in good yields. Furthermore,
the developed methodology was applied to the carbon isotope substitution
of several pharmaceutically active compounds, whereby complete carbon-13
labeling was successfully accomplished. It was initially proposed
that the carboxylation step would proceed via the in situ formation of a nickellacarboxylate, generated by CO insertion into
the Ni–alkoxide bond. However, preliminary mechanistic investigations
suggest an alternative pathway involving attack of an open shell species
generated from the alkyl halide to a metal ligated CO to generate
an acyl NiIII species. Subsequent reductive elimination
involving the alkoxide eventually leads to carboxylate formation.
An excess of the alkoxide was essential for obtaining a high yield
of the product. In general, the presented methodology provides a simple
and convenient setup for the synthesis and carbon isotope labeling
of aliphatic carboxylates, while providing new insights about the
reactivity of the N2N nickel pincer complex applied.
Catalyst encapsulation is examined as a means of increasing the productivity of olefin metathesis catalysts. Commercially available, cationic ruthenium metathesis catalysts were incorporated into a supramolecular resorcin[4]arene capsule. Encapsulation increased catalyst stability in water‐saturated toluene, delivering higher metathesis yields than the parent, non‐encapsulated Hoveyda catalyst in the same reaction medium.
Herein we disclose the synthesis of sterically encumbered dialkylnickel(II) complexes bearing 2,9-dimethyl-1,10phenanthroline ligands. A comparison with their unsubstituted analogues by both X-ray crystallography and theoretical calculations revealed significant distortions in their molecular structures. Eyring plots along with stoichiometric and photoexcitation studies revealed that sterically encumbered dialkylnickel(II) complexes enable facile C(sp 3 )−C(sp 3 ) reductive elimination, thus offering an improved understanding of Ni catalysis.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.